Related Experiment Video
Updated: Feb 1, 2026

Assessing Hepatic Metabolic Changes During Progressive Colonization of Germ-free Mouse by 1H NMR Spectroscopy
Published on: December 15, 2011
Hepatitis elimination by 2030: Progress and challenges.
Yasir Waheed1, Masood Siddiq2, Zubia Jamil3
1Multidisciplinary Laboratory, Foundation University Medical College, Foundation University Islamabad, Islamabad 44000, Pakistan. yasir.waheed@fui.edu.pk.
Global viral hepatitis elimination efforts face significant challenges. Despite progress in hepatitis B vaccination, low diagnosis rates and funding gaps hinder the 2030 targets for hepatitis B and C.
Area of Science:
- Public Health
- Infectious Diseases
- Global Health Policy
Background:
- Viral hepatitis affects over 300 million globally, causing 1.3 million deaths annually.
- The 2016 Global Health Sector Strategy aims to eliminate viral hepatitis by 2030, with only 12 countries currently on track.
- Progress includes high hepatitis B virus (HBV) vaccination rates (87% for 3 doses), but birth dose coverage is only 46%.
Discussion:
- Significant improvements in blood and injection safety are crucial.
- Hepatitis B and C diagnosis rates remain critically low, with only 11% of cases identified, highlighting the need to find 'missing millions'.
- While hepatitis C drug pricing has decreased, only 3 million cases were treated by 2016.
Key Insights:
- Low diagnosis rates and insufficient treatment coverage are major barriers to hepatitis elimination.
- Lack of dedicated funding from global donors and financial constraints in low- and middle-income countries impede hepatitis control programs.
- Achieving hepatitis elimination requires substantial financial investment and political will.
Outlook:
- Hepatitis elimination by 2030 is achievable but necessitates increased global financial commitment and political support.
- Collaboration with civil societies, pharmaceutical companies, and medical industries is essential for successful hepatitis control.
- Sustained efforts in vaccination, diagnosis, treatment, and prevention are vital for future progress.
Related Concept Videos
Elimination Kinetics: First-Order and Zero-Order
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Elimination Reactions
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Radical Formation: Elimination
Gaussian Elimination: Problem Solving
Kinetics of Drug Elimination
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...

